Through literature search and selection, a total of 15 case-control studies in 14 publications [7], [21]–[33], which included 14 studies for Tyr113His and 13 studies for His139Arg polymorphisms, were found to examine the EPHX1 polymorphisms and CRC susceptibility. This evidence concerns the gene EPHX1 and colorectal carcinoma.